Latest Capital Management News

Michael Hill International has successfully refinanced its $90 million debt facility, securing improved margins and extending the term to August 2028 with the addition of Commonwealth Bank as a new lender.

Harvest Technology Group has drawn down an additional $1 million from its $6 million RiverFort funding facility, aiming to accelerate growth and strengthen its balance sheet.

TasFoods Ltd has secured shareholder approval to sell its Pyengana Dairy business and to execute a selective buy-back of nearly 50 million shares, marking a pivotal moment in its strategic reshaping.

Carlton Investments Limited has announced an on-market buy-back of up to 115,000 ordinary shares, set to run throughout 2026. The move signals a strategic capital management effort without requiring shareholder approval.

Provaris Energy has raised $500,000 through a share placement to advance its proprietary hydrogen tank prototype and a joint venture on low-pressure liquid CO₂ storage, signaling strong board confidence and strategic momentum.

Resource Minerals International Ltd has successfully raised $1 million through a share placement to fund exploration projects across Saudi Arabia, Tanzania, and Finland, while also achieving a debt-free status.

SunRice reported a 14% rise in net profit for the first half of FY26 despite a revenue dip, reaffirming its growth outlook and updating paddy price guidance amid a forecast drier season.

HealthCo Healthcare & Wellness REIT confirms full rent payment from Healthscope and has conditional agreements with alternative tenants for its hospital portfolio, while suspending its December quarter distribution to preserve liquidity.

GemLife has secured a $21 million greenfield site in Townsville, Queensland, aiming to develop over 500 new homes and boost its Land Lease Community portfolio.

IDP Education has updated its revenue recognition policy to recognise Student Placement revenue at census date across all jurisdictions, leading to restated FY25 financials and reaffirmed FY26 guidance.

ActivEX Limited has raised $100,000 through a strategic share placement to Business Victor Investments, aiming to accelerate its exploration projects and strengthen working capital.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.